This document does not include all diseases
General effective rate for stem cell therapy is 96%.
Patients experience better memory and temper control. An improved sleep pattern and communication skill as well as decreased suicidal thoughts.
The stem cell department started treating cerebral palsy in 2004 and has successfully treated more than 3900 patients in total, which includes patients suffering from spastic, athetoid, mixed and ataxic type of cerebral palsy. The improvement rate observed so far is up to 96%. Reduction of abnormal muscular tension, better speech, motor and sensory function are all some of the improvements as well as sleep patterns and appetite. The younger a patient is the better response he/she has to the treatment. According to the hospital’s post-treatment follow-up data most patients have showed considerable signs of improvement after the treatment.
From its start in April 2010 up till the end of 2014, the department treated more than 265 patients of type 2 diabetes, and the treatment is effective for over 92% of patients. As well as 60% of patients have a better blood glucose control with half dose of the insulin than before. After the first course of treatment, 30% of patients can stop using insulin and oral hypoglycemic drugs. The treatment is effective to improve the blurred vision caused by diabetic retinopathy and diabetic peripheral neuropathy (DPN), and it also treat the symptoms such as numbness, feeling of cold, needle punching pain and feeling of electrical shock in the limbs.
The department has treated more than 65 patients with type 1 diabetes, and the patients have steadier blood sugar concentration and use less insulin than before, which reduce the chances of having acute complications such as diabetic ketoacidosis and hypoglycemia, and improved patient’s living quality.
Within three years we have treated over 62 patients with liver diseases or cirrhosis totally, including 33 cases of cirrhosis developed from hepatitis B (Child-Pugh 2-3).The overall efficiency rate is 87%. There has been a significant decrease in ascites, jaundice and pruritis as well as digestive symptoms (anorexia and abdominal swelling), with improved hepatic function and hypersplenism. The liver of some people who had smaller and sclerotic liver became larger and plump after stem cell transplantation. The condition of alcoholic cirrhosis patients improved more obviously than that of viral cirrhosis.
Till the end of 2014, the department had treated 68 patients of multiple system atrophy, with 49 male patients and 19 female patients, including 10 hereditary cases, with patients between 28-66 years of age.
There is reduction in muscular tension. Improved deglutition, speech, gait and posture. Reduced postural hypotension as well.
The follow-up data confirms that patient’s condition keeps on improving after treatment. But it shouldn’t be forgotten that all the transplantation of neurological stem cells can not cure multiple system atrophy, it can only improve patient’s condition and slow down or even stop disease progress.
General effective rate for stem cell therapy is 93%.
Tremors better controlled. Speech, memory and gait improved.
Till the end of 2014, the department has treated 3166 patients with sequela of spinal cord injury, including 1452 patients with cervical cord injury, 1193 patients with thoracic cord injury (do not include T12-L1), 216 patients with both cervical cord and thoracic cord injury, and 305 patients with thoracic and lumbar cord injury (mainly T12-L1). The improvement rate of patients with sequele of spinal cord injury has reached 96%.
There is better motor and sensory function. Restored body temperature, improved postural hypotension, urinary incontinence and dysdefecation.
Till the end of 2014, the department has treated 1002 patients of sequela. Among these patients, the longest onset time is 19 years, and the shortest is one month. The improvement rate of stroke sequela is 86%.
There was seen lower muscular tension and improved motor function and flexibility in these patients. Better sensation, circulation and facial expressions as well as improved speech. Normally, the shorter course of disease, the better therapeutic effect would be.
The department has had more than 1660 patients of traumatic brain injury (post-traumatic brain syndrome) and the recorded rate of improvement has been up to 92%.
Improved higher functions of brain (communication skills, memory and analytical thinking) seen. Reduced tension and increased muscle strength with improved sensory function and mood as well. Decreased epileptic fits.
They have had great success in the treatment procedure as patients have shown remarkable signs of recovery and have returned for the later phases of the treatment. The youngest patient that has been treated was 2 years old and the oldest patient was 56 years old. According to the duration after the patient sustained the injury and the hospital had success in treating, the patient with the shortest duration came to the stem cell department 2 weeks after the injury and the patient with the longest duration came 15 years after injury.
Up till now the department has treated about 201 cases of all kinds of intestinal problems, with an improvement rate of 99%. Among all disease being treated, Ulcerative Colitis’s treatment effect is the best. Many patients have been completely cured already.
Relief or disappearance of abdominal pain, abdominal distension, tenesmus and fever as well as improved appetite and bowel symptoms seen.
According to the post-treatment follow-up data most patients have showed considerable signs of improvement after the treatment. That is the reason this treatment is widely accepted by patients and their families, and they have continued with the second, third and fourth stages of the treatment plan, as after each stage of treatment the condition of the patients showed considerable signs of improvement.
Another factor which cannot be ignored is that stem cell treatment like all other treatments varies in regard to effectiveness from patient to patient, that is the reason we are still conducting further research on it to improve its effectiveness, which it has over time, so that patients can benefit more and more from it.